Navigation Links
Cardiac Science Announces Third Quarter Results
Date:11/9/2009

http://www.cardiacscience.com/cardiology-products/data-management-and-connectivity/heartcentrix-cardiac-data-management-connectivity.htm?utm_source=pr&utm_medium=pr&utm_campaign=pr&utm_keyword=connect-with-HIS">connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The Company sells a variety of related products and consumables and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick(®), HeartCentrix(®), Powerheart(®), and Quinton(®) brands, is headquartered in Bothell, Washington. The Company distributes its products in nearly 100 countries worldwide, with operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit http://www.cardiacscience.com.

Forward-Look
'/>"/>

SOURCE Cardiac Science Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related medicine technology :

1. Personalized Medicine - The Genomic Revolution in Cardiac Care
2. FAU Receives Patent for Invention Which Induces and Restores Cardiac Muscle Function
3. Signalife Completes Testing of Modules for Holter and Intra-Cardiac Monitor
4. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
5. Study Shows Vernakalant Hydrochloride is Effective in Conversion to Normal Heart Rhythm in Atrial Fibrillation Patients Following Cardiac Surgery
6. FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium)
7. Do-It-Yourself Cardiac Bypass Surgery: All You Need is Walking Shoes
8. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
9. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
10. DATATRAK and COResearch to Collaborate on Six Cardiac Safety Projects
11. Study Finds PCI Safe, Effective Despite Off-Site Cardiac Surgery

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...,, NEWYORK,Nov.25/PRNewswire/--Reportlinker.c...initscatalogue: ,, PainManagement-GlobalTrend...in-Management---Global-Trends.html ,, Widespre...mentclinics,andtheadventofnewdrugshaveacceleratedt...reformsandreimbursementstructurecontinuetoshapedem...
(Date:11/24/2009)...,, BETHESDA,Md.,Nov.24/PRNewswire-Asia/--Chin...leadingindependentAmericanproviderofWestern,health...a,today,announcedthattheCompanywillattendthe21stAn...obeheldDecember1-2,2009,atthe,NewYorkPalaceHotel. ...:30amETonTuesday,December1,2009,andholdone-on-one...
(Date:11/24/2009)...,, SANDIEGO,Nov.24/PRNewswire-FirstCall/--Ana...aythatitwillpresentatthe21stAnnualPiperJaffrayHeal...EST(6:00a.m.PST).TheconferenceisbeingheldatTheNewY...fExecutiveOfficerofAnadys,willprovideanoverviewofA...A773. ,, Thecorporatepresentationwillbesimultan...
Breaking Medicine Technology:Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Chindex International to Present at Piper Jaffray Health Care Conference 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2MHPA Leading Association Representing Medicaid Health Plans Issues Statement on Proposed California SCHIP Elimination 47534 1MHPA Leading Association Representing Medicaid Health Plans Issues Statement on Proposed California SCHIP Elimination 47534 2IMPACT Study Showed Longer Valcyte 28R 29 28valganciclovir hydrochloride tablets 29 Treatment Demonstrated Better Protection Against Cytomegalovirus 4505 1IMPACT Study Showed Longer Valcyte 28R 29 28valganciclovir hydrochloride tablets 29 Treatment Demonstrated Better Protection Against Cytomegalovirus 4505 2IMPACT Study Showed Longer Valcyte 28R 29 28valganciclovir hydrochloride tablets 29 Treatment Demonstrated Better Protection Against Cytomegalovirus 4505 3IMPACT Study Showed Longer Valcyte 28R 29 28valganciclovir hydrochloride tablets 29 Treatment Demonstrated Better Protection Against Cytomegalovirus 4505 4IMPACT Study Showed Longer Valcyte 28R 29 28valganciclovir hydrochloride tablets 29 Treatment Demonstrated Better Protection Against Cytomegalovirus 4505 5Nuvilex Launches Video Marketing Campaign 47528 1Nuvilex Launches Video Marketing Campaign 47528 2Nuvilex Launches Video Marketing Campaign 47528 3
... Activity and Long-Term Tumor Re... Trubion Pharmaceuticals Inc.,(Nasdaq: TRBN ) to...l data,showing that Trubion,s TRU-016 has potent a...rm tumor eradication in a human tumor xenograft mo...sponses. TRU-016 is Trubion,s,proprietary CD37-tar...
...ential New Front-Line Treatment ...2 Genzyme Corp.,(Nasdaq: GENZ ) reported prelimi...se 2 study examining the safety and effectiveness ...eviously untreated, older adult,patients with acut...enefit,from conventional "7+3" anthracycline plus ...
Other Medicine Technology:Trubion Announces Presentation of Positive TRU-016 Data at ASCO 2Trubion Announces Presentation of Positive TRU-016 Data at ASCO 3Trubion Announces Presentation of Positive TRU-016 Data at ASCO 4Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 2Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 3Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 4Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 5Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 6Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 7Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 8
(Date:11/25/2009)...ous discovery that grew out of a collaboration bet...ly offer hope to the nearly 10 million Americans w... Also known as hardening of the arteries, periphe...ory problem in which narrowed arteries reduce bloo... red flag for vascular disease, heart attack and s...
(Date:11/25/2009)...ready used to fight rheumatoid arthritis, could he... , WEDNESDAY, Nov. 25 (HealthDay News) -- A dru...d rheumatoid arthritis now also shows some promise...iabetes. , The drug, rituximab (Rituxan), helpe...n, even though the disease had destroyed some of t...
(Date:11/25/2009)...en plagued by neurological symptoms, study finds ...-- Neurological side effects are among the potenti...ular cancer who were treated with cisplatin-based ...y included 1,409 Norwegian men treated for unilate...ok part in a follow-up survey conducted from 1998 ...
(Date:11/25/2009)...GTON,Va.,Nov.25/PRNewswire-USNewswire/--TheAmerica...hCareFraudActof2009,"S.2128,whichisdesignedtosubst...fraudinMedicare.ThebillwasintroducedbySen.GeorgeLe...provisionstheAmericanAssociationforHomecareoutline...tionproposedtoCongressinFebruary.Thoseprovisionsin...
(Date:11/25/2009)... to treat colorectal cancer also can reverse a rar...line therapy for the disease, researchers at Vande..., Mntrier,s disease causes thickening of the stom...ting, as well as anemia and swelling in the feet a...reased risk for gastric cancer. Previously, the on...
Breaking Medicine News(10 mins):Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2
...inska Institutet, our everyday environments are fu...ying degrees when inhaled. Particularly damaging t...rground system in Stockholm, Sweden. "Luckily... My results show that there is every reason to spe...
...ving a toll on the health of the children of the c....// Fast and junk food are the most favoured...ocket money in these joints rather than have a dec...fast foods is resulting in an increase in the inci...
...a tight spot, defending its position against the l...ompany’s best-selling schizophrenia drug, Zyprexa....health risks of the drug, which is being linked to...ence has surfaced, that the company has indeed kep...
...y gatherings to prepare for, the winter season can...pectations and the stresses of holiday events can ... depression is one of the most common illnesses fo...director of the Adult Outpatient Psychiatry Servic...
...ure (USDA) have spent two years ascertaining the p... body composition of infants. The instrument ...em, the size of an infant was tested suitably unde...is team undertook a study of 56 healthy infants, c...
...ation and Authorization of Chemicals, has shifted ...icals to the// manufacturers. The chemical c... safe chemicals for safety of their business. ...roved this legislation on the use of toxic chemica...
Other Medicine News:Health News:Underground Air - Associated With - DNA Damages 2Health News:Child Obesity and Diabetes - A Major Problem in India, 2Health News:Mental Health Expert Offers Tips for a Happier Holiday Season 2Health News:Mental Health Expert Offers Tips for a Happier Holiday Season 3
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
Medicine Products: